Cholesterol medicine combo: better for numbers, not for heart attacks

Original Title

Ezetimibe plus statin combination versus double-dose statin in patients with dyslipidemia and atherosclerotic cardiovascular disease risk: a comprehensive systematic review and meta-analysis of 47 randomized controlled trials

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Doctors wanted to know if adding a second cholesterol drug (ezetimibe) to a statin works better than just using a higher dose of the statin alone.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Better cholesterol control did not lead to fewer heart attacks or deaths

Doctors often assume that lowering LDL cholesterol further will automatically reduce cardiovascular risk. This study challenges that assumption directly.

Practical Takeaways

If you're on a statin and not at your cholesterol goal, adding ezetimibe may help reach the target—but don’t expect extra protection against heart attacks.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

39%
Lower QualityOverall Score

Publication

Journal

Baylor University Medical Center Proceedings

Year

2025

Authors

A. Mahmoud, Hazem Mohamed Salamah, H. Rezq, Yazan Al-Mohtasib, Ali Ashraf Salah Ahmed, M. R. Abdelraouf, A. Amin, A. A. Ibrahim, Yasmine Adel Mohammed, O. Abdelwahab, M. Albarakat, S. Elshenawy, Husam Abu Suilik, B. Abdelazeem

3 citations
Analysis v1